RU94000695A - Agent showing antiallergic action - Google Patents

Agent showing antiallergic action

Info

Publication number
RU94000695A
RU94000695A RU94000695/14A RU94000695A RU94000695A RU 94000695 A RU94000695 A RU 94000695A RU 94000695/14 A RU94000695/14 A RU 94000695/14A RU 94000695 A RU94000695 A RU 94000695A RU 94000695 A RU94000695 A RU 94000695A
Authority
RU
Russia
Prior art keywords
agent
clinoptilolite
antiallergic action
zeolite
agent showing
Prior art date
Application number
RU94000695/14A
Other languages
Russian (ru)
Other versions
RU2082403C1 (en
Inventor
Л.Е. Панин
Т.А. Яковлева
Т.А. Третьякова
Original Assignee
Институт биохимии СО РАН
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Институт биохимии СО РАН filed Critical Институт биохимии СО РАН
Priority to RU94000695A priority Critical patent/RU2082403C1/en
Publication of RU94000695A publication Critical patent/RU94000695A/en
Application granted granted Critical
Publication of RU2082403C1 publication Critical patent/RU2082403C1/en

Links

Abstract

FIELD: medicine, allergology. SUBSTANCE: agent is zeolite-containing tuff (clinoptilolite). Agent is used at low curative dose and shows high curative effect in combination with nontoxicity and absence of by-side effects. Agent can be used in therapy against allergological diseases. EFFECT: high efficiency, simplified technology. 3 cl

Claims (1)

Изобретение относится к аллергологии и может найти применение в терапии аллергических болезней. Сущность изобретения заключается в применении цеолитсодержащего туфа (клиноптилолита) в качестве противоаллергического средства. Низкая лечебная доза, вводимая неинвазивным путем, при высоком лечебном эффекте, нетоксичность и отсутствие побочных эффектов, простота и дешевизна технологии получения средства делают целесообразным промышленное производство и медицинское применение природного цеолитсодержащего туфа (клиноптилолита).The invention relates to allergology and may find application in the treatment of allergic diseases. The invention consists in the use of zeolite-containing tuff (clinoptilolite) as an antiallergic agent. The low therapeutic dose administered non-invasively, with a high therapeutic effect, non-toxicity and the absence of side effects, the simplicity and low cost of the technology for producing the drug make it appropriate to industrial production and medical use of natural zeolite-containing tuff (clinoptilolite).
RU94000695A 1994-01-11 1994-01-11 Remedy of antiallergic action RU2082403C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU94000695A RU2082403C1 (en) 1994-01-11 1994-01-11 Remedy of antiallergic action

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU94000695A RU2082403C1 (en) 1994-01-11 1994-01-11 Remedy of antiallergic action

Publications (2)

Publication Number Publication Date
RU94000695A true RU94000695A (en) 1996-11-20
RU2082403C1 RU2082403C1 (en) 1997-06-27

Family

ID=20151310

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94000695A RU2082403C1 (en) 1994-01-11 1994-01-11 Remedy of antiallergic action

Country Status (1)

Country Link
RU (1) RU2082403C1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2125460C1 (en) 1997-11-17 1999-01-27 Закрытое акционерное общество научно-производственная фирма "Новь" Biostimulating agent
EP1971351A2 (en) * 2005-12-29 2008-09-24 Robert Basic Mineral-herbal preparation consisting of zeolite and astragalus membranaceus root extract to treat allergies

Also Published As

Publication number Publication date
RU2082403C1 (en) 1997-06-27

Similar Documents

Publication Publication Date Title
AU8335291A (en) Drugs, their manufacture, and their use as painkillers and/or to treat inflammations in humans and animals
BR9306841A (en) Pharmaceutical composition process for providing an antihistamine treatment which does not induce any significant cardiac arrhythmia in a human patient and use of a composition for the manufacture of a medicine for use in an antihistamine treatment
DE60022021D1 (en) Preparations containing apomorphine and sildenafil and their use for the treatment of erectile dysfunction
ID24901A (en) METHOD OF TREATMENT OF HIGH COAGAGULATION OR DEFICIENCY OF PROTEIN C OBTAINED
CA2503810A1 (en) Therapeutic agent for fibromyalgia
RU95101385A (en) Products containing g-csf and tnf-binding protein
DE60115432D1 (en) APOPTOTIC BODIES FOR USE IN THE TREATMENT OF T-CELL MEDICAMENT AND INFLAMMATORY DISEASES
DE60129322D1 (en) APOPTOTIC BODIES FOR USE IN THE TREATMENT OF NEURODE GENERATIVE AND OTHER NERVE DISEASES
BR0116653A (en) Medicinal product containing a polyamine as active substance
CA2450915A1 (en) Use of levosimendan and beta-adrenergic receptor antagonist for the treatment of heart failure
IL163091A (en) Medical product and pharmaceutical composition comprising as active ingredients a thrombolytic agent and levosimendan or a pharmaceutically acceptable salt thereof and the use of same in the manufacture of medicament for reducing mortality of patients with acute myocardial infarction
RU94000695A (en) Agent showing antiallergic action
KR100271087B1 (en) Protein synthesis stimulator comprising tcf-2 for the treatment of hypoproteinemia
US5576329A (en) Method for treating tendon or joint inflammation with papaverine HCL
CA2516458A1 (en) Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis
RU2177314C2 (en) Composition eliciting antiseptic, reparative and analgetic properties
ATE91890T1 (en) MANUFACTURE OF A DRUG AGAINST ARTHRITIS AND RHEUMATISM.
JP2001316293A5 (en)
Ayer et al. Dental treatment and heart valve complications in narcotic addicts
SE9101341D0 (en) NEW MEDICINAL USE
RU2200561C1 (en) Method for treating and preventing diseases
RU12352U1 (en) MEANS OF INFLUENCE ON BIOLOGICALLY ACTIVE POINTS AND ZONES OF REFLEXOTHERAPY
RU2002129097A (en) COMBINED THERAPIES USING VASCULAR HARMFUL ACTIVITY
RU94020964A (en) ELECTROSTATIC PLASTER "ELPLAST"
PharmD et al. Topical metronidazole for arterial insufficiency ulcers

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20060112